Neurodegenerative Diseases · 2004 · 54 citations · 0 references
MedicineNeurologyPharmacologyNeurobiology Of DiseaseNeurodegenerationNeuropharmacologyMolecular Basis Of NeurodegenerationNeurodegenerative Disease PharmacologyNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic PharmacologyNeuroprotective Drug Development
Background/Aims: Alzheimer’s disease (AD) is characterized by extracellular Aβ peptide deposition originating from amyloid precursor protein cleavage and intracellular neurofibrilla